Pharma

Synthesis of Novel Indenoisoquinolinium Topoisomerase I Inhibitors with Cytotoxicity in Human Cancer Cells Cultures

IPP Number 64034
Manager Thomas Hutton
Category Pharma

Design, Synthesis and Biological Evaluation of Cytotoxic 11-Alkenylindenoisoquinoline Topoisomerase I Inhibitors

IPP Number 63012
Manager Thomas Hutton
Category Pharma

Novel Prodrug Chemistry for the Intracellular Delivery of Tyrosine Phosphate Peptides and Peptidomimetics

IPP Number 60011
Manager Libby Hart-Wells
Category Pharma

Reversing P-Glycoprotein Medicated Drug Resistance

IPP Number 64884
Manager Libby Hart-Wells
Category Pharma

Multi-gram Total Syntheses of Zapotin and (±)-Abyssinone II, Cancer Chemopreventive Natural Products

IPP Number 64681
Manager Thomas Hutton
Category Pharma

Novel Drugs for the Prevention and Treatment of Inflammatory Diseases

IPP Number 64885
Manager Vicky Montenegro
Category Pharma

1,2-Dihydroellipticines with Activity Against CNS Specific Cancer Cell Lines

IPP Number 92061
Manager Thomas Hutton
Category Pharma

Cell Sorting and Diagnosing of HPV in a small sample of human cells

IPP Number 65282
Manager Libby Hart-Wells
Category Pharma

Novel Anti-Acrolein Therapy to Mitigate Myelin Damage in Multiple Sclerosis

IPP Number 65706
Manager Libby Hart-Wells
Category Pharma

Vaccine Linkers to Attach Proteins to Aluminum Hydroxide Adjuvants

IPP Number 65683
Manager Libby Hart-Wells
Category Pharma